AAAhmed Aldemerdash

Ahmed Aldemerdash

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ahmed Aldemerdash has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficacy and safety of hand suturing technique application in the endoscopic treatment of gastrointestinal tract tumors: a systematic review and meta-analysis

    by Mohamed Mahmoud Marey, Abdelaziz A. Awad, Amany Mahmoud Genidy, Aliaa Bahaa Abdelaziz, Menna M. Aboelkhier, Mazen Negmeldin Aly Yassin, Mohamed A. Aldemerdash, Ahmed Aldemerdash, Mohamed Eldesouki, Abdelrahman Shata, et al.


  • Comparing Umbilical Cord Management Strategies in Nonvigorous Newborns: A Systematic Review and Network Meta-analysis

    by Mohamed A. Aldemerdash, Mohammed Abdellatif, Doha Refaey, Yaser AbuSammour, Mahmoud Refaey, Abdelrhman Muwafaq Janem, Mohammed Tarek Hasan, Ahmed Aldemerdash, Huda Shihab, Naema Hamouda

    Nonvigorous newborns often require immediate resuscitation, and early cord clamping (ECC) is the conventional approach. Alternative strategies, such as intact cord resuscitation (ICR) and umbilical cord milking (UCM), may provide additional benefits without compromising safety. To compare the effectiveness and safety of different umbilical cord management strategies for nonvigorous newborns. We followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines and searched six databases for randomized controlled trials comparing different umbilical cord management approaches in nonvigorous newborns. Outcomes assessed included resuscitation effectiveness, hematological parameters, neonatal morbidities, and mortality. The Cochrane Collaboration tool RoB2 was used to assess the risk of bias. Ten studies with 2,541 newborns were included, with seven studies contributing to the meta-analysis. No significant differences were observed in resuscitation requirements, Apgar scores, or mortality between ECC, ICR, and UCM. However, at 5 minutes, ICR showed a small but statistically significant higher Apgar score compared with other interventions (mean difference [MD] = 0.3, 95% confidence interval [CI] [0.05, 0.55]). Additionally, heart rate was lower in the intact ICM (I-UCM) group (MD = −34.75 beats/min, 95% CI [−61.84, −7.66]). Cut UCM was associated with significantly higher serum ferritin levels at 6 weeks (MD = 40.44 µg/L, 95% CI [26.45, 54.43]). Initial hematocrit levels were also higher in the ICR group compared with ECC. ICR and UCM might be safe and effective alternatives to ECC for nonvigorous newborns, with potential hematological benefits. However, further large-scale studies are needed to confirm these findings and evaluate long-term neurodevelopmental outcomes.


  • Evaluation of cord management strategies in intrauterine growth-restricted infants: a systematic review and meta-analysis

    by Mohamed A. Aldemerdash, Mohammed Abdellatif, Merna Raafat Roshdy, Asmaa Zakaria, Ahmed Bayoumi, Mohammed Tarek Hasan, Yaser AbuSammour, Ahmed Aldemerdash, Doaa Mashaly, Naema Hamouda

    Delayed cord clamping (DCC) has been widely adopted in both term and preterm infants to improve neonatal outcomes by increasing blood volume and supporting oxygenation. However, the optimal cord management for intrauterine growth-restricted (IUGR) infants is unclear. To systematically review and meta-analyze the effects of DCC compared to early cord clamping (ECC) in IUGR infants. We followed the PRISMA guidelines for meta-analysis. Six databases were searched for randomized controlled trials (RCTs) and observational studies comparing DCC and ECC in IUGR infants, focusing on neonatal resuscitation measures, hematological parameters, morbidities, and mortality. The Cochrane Collaboration tool and Newcastle–Ottawa scale were used for RCTs and observational studies, respectively. Eight studies with 1531 participants were included, comprising six RCTs and two observational studies. Serum ferritin at 3 months and initial Hb were significantly higher in the DCC group (MD: 36.16 ng/ml [95% CI: 34.09, 38.24]), (MD: 1.64 gm/dl [95%CI: 0.88, 2.4]) respectively. The risk of polycythemia was higher in the DCC group (RR 1.88, 95% CI [1.27, 2.8]), without an increase in the peak total serum bilirubin or the need for exchange transfusion. Conclusion: DCC may be beneficial and safe in IUGR infants, improving hematological parameters without affecting neonatal morbidity and mortality. Further high-quality, large trials are needed to confirm these findings and assess neurodevelopmental impact.